1. ALLA AKTIER
  2. NYHETER
  3. C-RAD

C-RAD

Nyheter C-RAD Nyheter alla bolag

Repurchase of C-RAD B-shares week 33 - 2024

MARKN.

Between 12th and 14th of August 2024 C-RAD AB (publ) (LEI code 549300SPXLHF15W2CU25), has repurchased in total 30,000 own B-shares (ISIN: SE0002016352).

The repurchase is carried out in accordance with the Annual General Meeting's authorization to the Board to acquire shares in the Company. The purpose of the repurchase is to cover the Company’s obligations under previously resolved incentive programs.

DateAggregated daily volume (number of shares):Weighted average share price per day (SEK):Total daily transaction value (SEK):
2024-08-1211,00044.1984486,182
2024-08-1310,00044.0621440,621
2024-08-149,00043.9817395,835
Total:30,00044.08801,322,639

All acquisitions have been carried out on Nasdaq Stockholm by Pareto on behalf of C-RAD. Following the above acquisitions, C-RAD AB holds a total of 188,500 class B-shares in treasury as per 14 August 2024, equivalent to 0.56 percent of the total number of shares outstanding, and 0.45 percent of the votes.

The total number of shares outstanding in C-RAD AB, including shares held in treasury, is 33,766,935, where of 862,887 are Class A-shares and 32,904,048 are Class B-shares.

For further information:

Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Jonas Reinhammar, Interim CFO, +46 (0)762 406 402, investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments

Repurchase of C-RAD B-shares week 33 - 2024

Datum 2024-08-20, kl 08:15
Källa MFN
Bifogade filer
Repurchase of C-RAD B-shares week 33 - 2024
Affiliate
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet